---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-23-000073"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2023-09-07T23:59:59+00:00"
generated_at: "2026-06-10T22:45:34.056019+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience announces 1-for-250 reverse stock split effective Sept 8, 2023

## Summary
- Reverse split at 1:250 reduces outstanding shares from ~3.078B to ~12.3M.
- Authorized shares reduced from 5B to 20M; ticker SKYE gets 'D' for 20 trading days.
- No stockholder vote required; fractional shares rounded up to whole shares.
- Effective Sept 8, 2023; new CUSIP 83086J200 for common stock.
- Each holder's percentage ownership unchanged except for rounding adjustments.

## SEC filing metadata
- accession: 0001516551-23-000073
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2023-09-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655123000073/0001516551-23-000073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655123000073/skye-20230906.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-23-000073
- JSON: https://secwatch.observer/filing/0001516551-23-000073.json
- Plain text: https://secwatch.observer/filing/0001516551-23-000073.txt

## Key facts
- Governance Changes
  Skye Bioscience, Inc.: Reverse stock split at a ratio of one-for-250 and reduction of authorized shares from 5,000,000,000 to 20,000,000, effective via Certificate of Change and Certificate of Correction (effective 2023-09-08).
  - Change: bylaw amendment
  - Effective: 2023-09-08
  source text: On September 6, 2023, Skye Bioscience, Inc. (the “Company”) filed a Certificate of Change and Certificate of Correction with the Secretary of State of the State of Nevada, which will effect a reverse stock split (the “Reverse Split”), at a ratio of one-for-250, of the Company’s issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655123000073/0001516551-23-000073-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.